439 related articles for article (PubMed ID: 15824416)
1. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
[TBL] [Abstract][Full Text] [Related]
2. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
3. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
Oktay K; Hourvitz A; Sahin G; Oktem O; Safro B; Cil A; Bang H
J Clin Endocrinol Metab; 2006 Oct; 91(10):3885-90. PubMed ID: 16882752
[TBL] [Abstract][Full Text] [Related]
4. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.
Azim A; Oktay K
Fertil Steril; 2007 Sep; 88(3):657-64. PubMed ID: 17428480
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
6. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
8. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
Azim AA; Costantini-Ferrando M; Lostritto K; Oktay K
J Clin Endocrinol Metab; 2007 Jun; 92(6):2197-200. PubMed ID: 17356042
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
[TBL] [Abstract][Full Text] [Related]
10. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
11. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols.
Ben-Haroush A; Farhi J; Ben-Aharon I; Sapir O; Pinkas H; Fisch B
Isr Med Assoc J; 2011 Dec; 13(12):753-6. PubMed ID: 22332446
[TBL] [Abstract][Full Text] [Related]
12. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
Garcia-Velasco JA; Moreno L; Pacheco A; Guillén A; Duque L; Requena A; Pellicer A
Fertil Steril; 2005 Jul; 84(1):82-7. PubMed ID: 16009161
[TBL] [Abstract][Full Text] [Related]
13. Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
Rossi E; Morabito A; De Maio E; Di Rella F; Esposito G; Gravina A; Labonia V; Landi G; Nuzzo F; Pacilio C; Piccirillo MC; D'Aiuto G; D'Aiuto M; Rinaldo M; Botti G; Gallo C; Perrone F; de Matteis A
J Clin Oncol; 2008 Jan; 26(2):264-70. PubMed ID: 18086795
[TBL] [Abstract][Full Text] [Related]
14. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.
Checa Vizcaíno MA; Corchado AR; Cuadri ME; Comadran MG; Brassesco M; Carreras R
Reprod Biomed Online; 2012 Jun; 24(6):606-10. PubMed ID: 22503276
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
16. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
[TBL] [Abstract][Full Text] [Related]
18. Techniques for fertility preservation in patients with breast cancer.
Dunn L; Fox KR
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
[TBL] [Abstract][Full Text] [Related]
19. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.
Oktay K; Buyuk E; Davis O; Yermakova I; Veeck L; Rosenwaks Z
Hum Reprod; 2003 Jan; 18(1):90-5. PubMed ID: 12525446
[TBL] [Abstract][Full Text] [Related]
20. Fertility preservation in young women undergoing breast cancer therapy.
Sonmezer M; Oktay K
Oncologist; 2006 May; 11(5):422-34. PubMed ID: 16720842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
